Literature DB >> 20721642

Helicobacter pylori eradication: are we really all equal? A controlled study in native and immigrant population.

Luigi Gatta1, Francesco Di Mario, Dino Vaira, Angelo Franzé, Massimo Rugge, Alberto Pilotto, Paolo Lucarini, Maurizio Lera, Giulia Fiorini, Valentina Castelli, Enkleda Kajo, Carmelo Scarpignato.   

Abstract

Italy's shift to a tertiary economy has modified the working market, concentrating demand also on unqualified one, which includes most immigrants. It is also well established that low socio-economical conditions are associated with an increased prevalence of H. pylori infection. The aims of this study were to compare: (1) the efficacy of a 7 days triple therapy in immigrant and in Italian patients; (2) the prevalence of PUD between these two groups of patients. A total of 116 consecutive immigrant and 112 Italian H. pylori infected patients were recruited between 2007 and 2008. Patients underwent (13)C-UBT, endoscopy with biopsies, and were offered a 7-day triple therapy. Eradication rate (ER) was assessed 8 weeks after the end of the treatment using (13)C-UBT. The two populations differed for median age (p < 0.01), prevalence of PUD (p < 0.01), and smoking status (p < 0.01). The ER according to the ITT analysis was 70% for Italian and 48.3% for immigrant (p < 0.01). Multivariate analysis including country of origin, sex, age, PUD, smoking, and alcohol status found that immigrant had an adjusted OR for not eradicating of 2.14 (p = 0.03). In immigrant patients resident in Italy, performance of triple therapy was lower than expected. Further studies are demanded to confirm and clarify these intriguing results.

Entities:  

Mesh:

Year:  2010        PMID: 20721642     DOI: 10.1007/s11739-010-0443-0

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  23 in total

1.  Clarithromycin-resistant genotypes and eradication of Helicobacter pylori.

Authors:  Vincenzo De Francesco; Marcella Margiotta; Angelo Zullo; Cesare Hassan; Laura Troiani; Osvaldo Burattini; Francesca Stella; Alfredo Di Leo; Francesco Russo; Stefania Marangi; Rosa Monno; Vincenzo Stoppino; Sergio Morini; Carmine Panella; Enzo Ierardi
Journal:  Ann Intern Med       Date:  2006-01-17       Impact factor: 25.391

2.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.

Authors:  P Malfertheiner; F Megraud; C O'Morain; F Bazzoli; E El-Omar; D Graham; R Hunt; T Rokkas; N Vakil; E J Kuipers
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

3.  The prevalence of Helicobacter pylori infection in western Romania.

Authors:  Ioan Sporea; Alina Popescu; Mark van Blankenstein; Roxana Sirli; Mircea Focşea; Mirela Dănilă
Journal:  Rom J Gastroenterol       Date:  2003-03

Review 4.  Helicobacter pylori in eastern European countries: what is the current status?

Authors:  T Matysiak-Budnik; F Mégraud
Journal:  Gut       Date:  1994-12       Impact factor: 23.059

Review 5.  Treatment of Helicobacter pylori infection.

Authors:  Lucas G Cavallaro; Brian Egan; Colm O'Morain; Francesco Di Mario
Journal:  Helicobacter       Date:  2006-10       Impact factor: 5.753

6.  The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis.

Authors:  Sara Padol; Yuhong Yuan; Marroon Thabane; Ireneusz T Padol; Richard H Hunt
Journal:  Am J Gastroenterol       Date:  2006-07       Impact factor: 10.864

7.  High eradication rates of Helicobacter pylori with a new sequential treatment.

Authors:  A Zullo; D Vaira; N Vakil; C Hassan; L Gatta; C Ricci; V De Francesco; M Menegatti; A Tampieri; F Perna; V Rinaldi; F Perri; C Papadìa; F Fornari; S Pilati; L S Mete; A Merla; R Potì; G Marinone; A Savioli; S M A Campo; D Faleo; E Ierardi; M Miglioli; S Morini
Journal:  Aliment Pharmacol Ther       Date:  2003-03-01       Impact factor: 8.171

Review 8.  H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer.

Authors:  J P Gisbert; S Khorrami; F Carballo; X Calvet; E Gené; J E Dominguez-Muñoz
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 9.  Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children.

Authors:  Luigi Gatta; Nimish Vakil; Gioacchino Leandro; Francesco Di Mario; Dino Vaira
Journal:  Am J Gastroenterol       Date:  2009-10-20       Impact factor: 10.864

10.  Patient compliance and the conduct and interpretation of therapeutic trials.

Authors:  R B Haynes; R Dantes
Journal:  Control Clin Trials       Date:  1987-03
View more
  4 in total

1.  Helicobacter pylori in immigrants: a "foreign" bacterium?

Authors:  Angelo Zullo; Francesca Cristofari; Maria Consiglia Bragazzi; Cesare Hassan
Journal:  Intern Emerg Med       Date:  2010-11-20       Impact factor: 3.397

2.  Role of gastritis pattern on Helicobacter pylori eradication.

Authors:  Angelo Zullo; Carola Severi; Lucy Vannella; Cesare Hassan; Andrea Sbrozzi-Vanni; Bruno Annibale
Journal:  Intern Emerg Med       Date:  2011-11-22       Impact factor: 3.397

3.  Nickel free-diet enhances the Helicobacter pylori eradication rate: a pilot study.

Authors:  M Campanale; E Nucera; V Ojetti; V Cesario; T A Di Rienzo; G D'Angelo; S Pecere; F Barbaro; G Gigante; T De Pasquale; A Rizzi; G Cammarota; D Schiavino; F Franceschi; A Gasbarrini
Journal:  Dig Dis Sci       Date:  2014-03-05       Impact factor: 3.199

4.  Antibiotic Resistance and Therapy for H. pylori Infection in Immigrant Patients Treated in Italy.

Authors:  Giulia Fiorini; Ilaria Maria Saracino; Angelo Zullo; Matteo Pavoni; Laura Saccomanno; Tiziana Lazzarotto; Rossana Cavallo; Guido Antonelli; Berardino Vaira
Journal:  J Clin Med       Date:  2020-05-01       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.